Search Results - Gary Cutter

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should care by Justin M. Leach, Inmaculada Aban, Gary Cutter, Michael Benatar

    Get full text
    Article


  2. 2

    Antibody responses to Chlamydia trachomatis vaccine candidate antigens in Chlamydia-infected women and correlation with antibody-mediated phagocytosis of elementary bodies by Hong Yu, William M. Geisler, Chuanbin Dai, Kanupriya Gupta, Gary Cutter, Robert C. Brunham

    Get full text
    Article


  3. 3

    Study protocol: exercise training for treating major depressive disorder in multiple sclerosis by Robert W. Motl, Charles H. Bombardier, Jennifer Duffecy, Brooks Hibner, Alison Wathen, Michael Carrithers, Gary Cutter

    Published in BMC Neurology (2024-04-01)
    Get full text
    Article


  4. 4

    Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis by Marissa Betts, Kyle Fahrbach, Binod Neupane, Mahmoud Slim, Maria Pia Sormani, Gary Cutter, Thomas PA Debray, Marvin Rock

    Article


  5. 5

    A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod by Amber Salter, Samantha Lancia, Gary Cutter, Ruth Ann Marrie, Jason P. Mendoza, James B. Lewin, Robert J. Fox

    Get full text
    Article


  6. 6

    Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) by Itay Lotan, Gabriela Romanow, Rebecca Salky, Negar Molazadeh, Anastasia Vishnevetsky, Monique Anderson, Philippe Antoine Bilodeau, Gary Cutter, Michael Levy

    Get full text
    Article


  7. 7

    Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1 by Nicole J. Ullrich, Jonathan M. Payne, Karin S. Walsh, Gary Cutter, Roger Packer, Kathryn North, Celiane Rey‐Casserly, the NF Clinical Trials Consortium

    Get full text
    Article


  8. 8

    Clinical trials in multiple sclerosis: potential future trial designs by Navid Manouchehri, Yinan Zhang, Amber Salter, Rehana Z. Hussain, Hans-Peter Hartung, Bernhard Hemmer, Ralf Linker, Benjamin M. Segal, Gary Cutter, Olaf Stüve

    Get full text
    Article


  9. 9

    Gender differences in quality of life among patients with myasthenia gravis in China by Dong Dong, Marc Ka-chun Chong, Yushan Wu, Henry Kaminski, Gary Cutter, Xianhao Xu, Haifeng Li, Chongbo Zhao, Jian Yin, Siyue Yu, Jianfeng Zhu

    Published in Health and Quality of Life Outcomes (2020-09-01)
    Get full text
    Article


  10. 10

    Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis by Robert Motl, Whitney Neal, Deborah Backus, Jeffrey Hebert, Kevin McCully, Francois Bethoux, Prudence Plummer, Alexander Ng, John Lowman, Hollie Schmidt, Robert McBurney, Gary Cutter

    Published in BMC Neurology (2024-10-01)
    Get full text
    Article


  11. 11

    Transcallosal and Corticospinal White Matter Disease and Its Association With Motor Impairment in Multiple Sclerosis by Keejin Yoon, Keejin Yoon, Derek B. Archer, Derek B. Archer, Margareta A. Clarke, Seth A. Smith, Ipek Oguz, Gary Cutter, Junzhong Xu, Francesca Bagnato, Francesca Bagnato

    Published in Frontiers in Neurology (2022-06-01)
    Get full text
    Article


  12. 12

    Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis by Gary Cutter, Sarah Hopkins, Patricia Plumb, Benjamin Greenberg, Janet Dean, Allen Desena, Chitra Krishnan, Carlos Pardo, Albert Recio, Teri Schreiner, E Ann Yeh, Morgan McCreary

    Published in BMJ Neurology Open (2021-06-01)
    Get full text
    Article


  13. 13

    The emerging postural instability phenotype in idiopathic Parkinson disease by Frank M. Skidmore, William S. Monroe, Christopher P. Hurt, Anthony P. Nicholas, Adam Gerstenecker, Thomas Anthony, Leon Jololian, Gary Cutter, Adil Bashir, Thomas Denny, David Standaert, Elizabeth A. Disbrow

    Published in npj Parkinson's Disease (2022-03-01)
    Get full text
    Article


  14. 14

    Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysis by Guillemette de la Borderie, Damien Chimits, Babak Boroojerdi, Melissa Brock, Petra W. Duda, Fiona Grimson, Paul Mahoney, Foteini Strimenopoulou, Gary Cutter, Inmaculada Aban, Susanna Brauner, Malin Petersson, James F. Howard, Nathan Bennett

    Get full text
    Article


  15. 15

    Quantitative sleep electroencephalogram and cognitive performance in Parkinson’s disease with and without rapid eye movement sleep behavior disorder by Adeel A. Memon, Adeel A. Memon, Corina Catiul, Zachary Irwin, Jennifer Pilkington, Raima A. Memon, Allen Joop, Kimberly H. Wood, Kimberly H. Wood, Gary Cutter, Svjetlana Miocinovic, Amy W. Amara, Amy W. Amara

    Published in Frontiers in Neurology (2023-09-01)
    Get full text
    Article


  16. 16

    Association between B-cell depletion and attack risk in neuromyelitis optica spectrum disorder: An exploratory analysis from N-MOmentum, a double-blind, randomised, placebo-control... by Jeffrey L. Bennett, Orhan Aktas, William A. Rees, Michael A. Smith, Michele Gunsior, Li Yan, Dewei She, Daniel Cimbora, Sean J. Pittock, Brian G. Weinshenker, Friedemann Paul, Romain Marignier, Dean Wingerchuk, Gary Cutter, Ari Green, Hans-Peter Hartung, Ho Jin Kim, Kazuo Fujihara, Michael Levy, Eliezer Katz, Bruce A.C. Cree

    Published in EBioMedicine (2022-12-01)
    Get full text
    Article


  17. 17

    Polygenic liability for anxiety in association with comorbid anxiety in multiple sclerosis by Kaarina Kowalec, Arvid Harder, Casandra Dolovich, Kathryn C. Fitzgerald, Amber Salter, Yi Lu, Charles N. Bernstein, James M. Bolton, Gary Cutter, John D. Fisk, Joel Gelernter, Lesley A. Graff, Sara Hägg, Carol A. Hitchon, Daniel F. Levey, Fred D. Lublin, Kyla A. McKay, Scott Patten, Amit Patki, Murray B. Stein, Hemant K. Tiwari, Jerry S. Wolinsky, Ruth A. Marrie

    Get full text
    Article


  18. 18

    Reproducibility of cognitive endpoints in clinical trials: lessons from neurofibromatosis type 1 by Jonathan M. Payne, Stephen J. C. Hearps, Karin S. Walsh, Iris Paltin, Belinda Barton, Nicole J. Ullrich, Kristina M. Haebich, David Coghill, Gerard A. Gioia, Alan Cantor, Gary Cutter, James H. Tonsgard, David Viskochil, Celiane Rey‐Casserly, Elizabeth K. Schorry, Joseph D. Ackerson, Laura Klesse, Michael J. Fisher, David H. Gutmann, Tena Rosser, Roger J. Packer, Bruce Korf, Maria T. Acosta, Kathryn N. North, the NF Clinical Trials Consortium

    Get full text
    Article


  19. 19

    The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care – updates at the 2023 plenary event by Paola Zaratin, Sara Samadzadeh, Sara Samadzadeh, Sara Samadzadeh, Meral Seferoğlu, Vito Ricigliano, Vito Ricigliano, Jonadab dos Santos Silva, Jonadab dos Santos Silva, Abdulkadir Tunc, Giampaolo Brichetto, Timothy Coetzee, Anne Helme, Usman Khan, Robert McBurney, Guy Peryer, Helga Weiland, Peer Baneke, Mario Alberto Battaglia, Valerie Block, Luca Capezzuto, Loïc Carment, Paolo Angelo Cortesi, Gary Cutter, Letizia Leocani, Letizia Leocani, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Jan Hillert, Jeremy Hobart, Kaisa Immonen, Paul Kamudoni, Rod Middleton, Patricia Moghames, Xavier Montalban, Liesbet Peeters, Maria Pia Sormani, Susanna van Tonder, Susanna van Tonder, Angela White, Giancarlo Comi, Patrick Vermersch

    Published in Frontiers in Neurology (2024-06-01)
    Get full text
    Article


Search Tools: